Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2024 May 1.

Published in final edited form as: J Thromb Thrombolysis. 2023 Feb 9;55(4):685–690. doi: 10.1007/s11239-023-02774-1

Table 2:

VTE recurrence rate at 12 months by anticoagulant and BMI/weight

	DOAC	Warfarin	OR
BMI category (kg/m²)
Overall	67/1823 (3.6%)	143/3668 (3.8%)	1.06 (0.79, 1.44)
≥35	66/1823 (3.6%)	141/3668 (3.8%)	1.06 (0.79, 1.44)
≥40	30/685 (4.4%)	58/1636 (3.5%)	0.80 (0.52, 1.27)
≥50	4/127 (3.1%)	16/433 (3.7%)	1.18 (0.42, 4.18)

35-<40	36/1138 (3.2%)	83/2032 (4.1%)	1.30 (0.88, 1.96)
40-<45	15/385 (3.9%)	27/780 (3.5%)	0.88 (0.47, 1.72)
45-50	11/173 (6.4%)	15/423 (3.5%)	0.54 (0.25, 1.23)

Weight (kg)
120-140	16/490 (3.3%)	32/912 (3.5%)	1.08 (0.59, 2.03)
≥140	9/230 (3.9%)	18/586 (3.1%)	0.78 (0.35, 1.84)